This study was conducted to determine the effects of administration of 25 mg of PGF2α (prostaglandin F2α) 7 d prior to the initiation of the 7-d CO-Synch + controlled internal drug release (CIDR) fixed-time artificial insemination (TAI) protocol in beef heifers. The additional PGF2α injection increased estrus response at the start of the protocol, and decreased estrus response prior to TAI. No differences were detected in pregnancy rates to AI (PR/AI) between treatments. 
Introduction
By controlling the bovine estrous cycle with exogenous hormones, TAI may be facilitated, and the time and labor associated with estrus detection may be reduced. Presynchronization involves the administration of preliminary hormones prior to the initiation of an estrus synchronization protocol. The utilization of GnRH or PGF2α before the commencement of a TAI protocol may increase the proportion of dominant follicles that respond to the first GnRH injection, and may therefore improve the synchronization of the subsequent follicular growth waves (Kojima et al. This study was performed to evaluate the effects of an injection of PGF2α 7 d prior to the initiation of the 7-d CO-Synch + CIDR protocol on fertility in replacement beef heifers. We hypothesized that an injection of PGF2α 7 d before the initiation of the 7-d CO-Synch + CIDR protocol would improve PR/AI by increasing the estrus response between d -14 and d -7, thereby increasing the proportion of heifers that respond to the PGF2α injection on d 0.
Materials and Methods
A total of 985 Bos taurus beef heifers were enrolled across 9 locations in 3 states (South Dakota, North Dakota, and Colorado). Within location, heifers were randomly assigned to 1 of 2 treatments: 1) estrus detection patches were applied on d -14, 100 μg of GnRH was administered at CIDR (1.38 g progesterone) insertion on d -7, 25 mg of PGF2α was administered at CIDR removal concurrently with a second estrus detection patch application on d 0, followed 54 ± 2 h later by the administration of 100 μg of GnRH and TAI (CONTROL; n = 496); or 2) heifers were treated the same as the CONTROL treatment with the addition of a 25 mg injection of PGF2α 7 d prior to CIDR insertion on d -14 (PRESYNCH; n = 489). Estrus detection patches were examined for activation on d -7 (EST1) and at the time of TAI (EST2). Estrus detection patches were considered activated when at least 50% of the rub-off coating was removed, or when the patch was absent. No less than 10 d after TAI, heifers were exposed to bulls for the remainder of the breeding season at 7 locations. Transrectal ultrasonography was performed between d 35 and 55 after TAI to determine the presence of a viable embryo, thereby assessing PR/AI. Final overall pregnancy rates were determined by transrectal ultrasonography at least 35 d after the end of the breeding season.
All data was analyzed as a completely randomized design using the GLIMMIX procedure of SAS (SAS Institute, Inc., Cary, N.C.) with heifer as the experimental unit.
Results
Between estrus patch application on d -14 and patch examination on d -7, estrus expression differed (P<0.001) between treatments. Estrus expression was greater in PRESYNCH compared with CONTROL treatments, and differed among locations (P<0.001). The percentage of heifers exhibiting estrus behavior between d-14 and d-7 ranged from 47.3 to 79.7% among locations; however, no treatment × location interaction was detected (P = 0.57).
Although heifers in the PRESYNCH treatment had a lower estrus response between d 0 and TAI compared with those in the CONTROL treatment, PR/AI did not differ (P = 0.74). In contrast, there was an effect of location (P = 0.02) on PR/AI, which ranged from 37.8 to 61.7%. No treatment × location interaction was detected (P = 0.69). At the conclusion of the breeding season, final pregnancy rates did not differ (P = 0.81) between CONTROL and PRESYNCH treatments respectively. Final pregnancy rates differed (P<0.001) among location, and ranged from 78.3 to 97.9%. , and an injection of GnRH and fixed-time artificial insemination (TAI) 54 ± 2 h later (n = 4 95). PRESYNCH: treated the same as CONTROL, but received an additional 25-mg injection of PGF2α 7 d prior to the first GnRH injection on d -14 (n = 489). Estrus detection patches were applied on d 0 and were examined for activation at the time of TAI. 2 SEM: Standard error of the mean between CONTROL and PRESYNCH treatments within row. 3 P-value represents the difference between CONTROL and PRESYNCH treatments within row. 4 Overall estrus response at the time of TAI differed (P<0.001) between treatments. w,x,y,z Percentages within column with different superscripts differ (P≤0.05). 
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